From breakthrough treatments to AI-driven diagnostics, healthcare is evolving faster than ever. With increasing healthcare ...

Reports Q4 revenue $73.69M, consensus $72.17M. Frederick Vogt, interim president and CEO of Iovance, stated, “In 2024, we successfully drove ...

Discover key insights from argenx's Q4 2024 earnings call, highlighting VYVGART's expansion, financial milestones, pipeline advancements, and ...

Implantable Drug Eluting Devices Market. The Global Implantable Drug Eluting Devices Market was valued at approximately USD ...

Future Market Insights (FMI), a leading authority in market research and consulting, has released an insightful forecast highlighting significant expansion in the global anatomic pathology market.

In 2021, the market was valued at USD 912.5 million, and it is projected to reach USD 1,841.2 million by 2028, growing at a CAGR of 11.0% during 2022-2028. Key factors driving this growth include: The ...

Despite a solid long-term growth story and strong cash reserves, the high VCYT stock valuation suggests a "hold" rating until ...

Q4 2024 Earnings Call Transcript February 24, 2025 Veracyte, Inc. beats earnings expectations. Reported EPS is $0.36, ...

In the UP State Focus Paper prepared by Nabard, the state is projected to have a consolidated credit potential of ₹7.69 ...

According to Statifacts, the global in vitro diagnostics market size is calculated at 104.84 billion in 2025 and is projected ...

The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...